Harbour Investments’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$473K Buy
4,556
+90
+2% +$9.59K 0.01% 1084
2025
Q4
$461K Buy
4,466
+329
+8% +$32K 0.01% 889
2025
Q3
$374K Sell
4,137
-313
-7% -$27.4K 0.01% 937
2025
Q2
$391K Buy
4,450
+394
+10% +$34.2K 0.01% 870
2025
Q1
$370K Buy
4,056
+532
+15% +$47.9K 0.01% 836
2024
Q4
$304K Buy
3,524
+99
+3% +$8.96K 0.01% 864
2024
Q3
$325K Buy
3,425
+488
+17% +$46.3K 0.01% 817
2024
Q2
$269K Buy
2,937
+5
+0.2% +$446 0.01% 834
2024
Q1
$266K Buy
2,932
+1,275
+77% +$112K 0.01% 811
2023
Q4
$135K Buy
1,657
+637
+62% +$49.9K 0.01% 1017
2023
Q3
$81.5K Hold
1,020
﹤0.01% 1125
2023
Q2
$80.4K Hold
1,020
﹤0.01% 1146
2023
Q1
$79.2K Hold
1,020
﹤0.01% 1150
2022
Q4
$79.3K Hold
1,020
﹤0.01% 1116
2022
Q3
$78K Hold
1,020
0.01% 1089
2022
Q2
$78K Buy
+1,020
New +$79.6K 0.01% 1089
2021
Q4
$79K Sell
1,020
-1,329
-57% -$98.8K ﹤0.01% 1071
2021
Q3
$171K Buy
2,349
+5
+0.2% +$373 0.01% 1104
2021
Q2
$171K Buy
2,344
+7
+0.3% +$499 0.01% 1123
2021
Q1
$161K Buy
+2,337
New +$161K 0.01% 1072

Other funds holding PPH